All In MedTech

Company

Orasure Technologies

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

OSUR

Nasdaq · ORASURE TECHNOLOGIES INC

Public float

$218M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$115M

Fiscal year ending Dec 31, 2025

Net income

-$68.7M

Fiscal year ending Dec 31, 2025

R&D spending

$42.5M

Fiscal year ending Dec 31, 2025

Cash

$148M

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

69.0M

As of Nov 2, 2026

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Orasure Technologies we have 5 shareholders with 5% or more and 1 government grant totalling $146K.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

No device trials list this company as lead sponsor.

Reports received

9

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

9

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231000
Jan 241000
Feb 244000
Mar 244000
Apr 240000
May 241000
Jun 240000
Jul 249000
Aug 242000
Sep 244000
Oct 241000
Nov 243000
Dec 244000
Jan 250000
Feb 250000
Mar 250000
Apr 250000
May 250000
Jun 250000
Jul 250000
Aug 250000
Sep 251000
Oct 250000
Nov 250000
Dec 250000
Jan 260000
Feb 266000
Mar 261000
Apr 260000
May 260000
Jun 260000
Jul 262000
Aug 260000
Sep 260000
Oct 260000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

11 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.